Stock Report

Cipla Reports Q1 FY27 Net Profit of ₹785.55 Crore; Revenue from Operations Rises 8.8% Sequential to ₹7,119.28 Crore

Posted On : 2026-07-24 10:19:04( TIMEZONE : IST )

Global pharmaceutical leader Cipla Limited today announced its unaudited consolidated financial results for the first quarter of Financial Year 2026-2027 (Q1 FY27) ended June 30, 2026.

The company registered a strong sequential recovery in both operational revenue and profitability, driven by core product sales, despite a high base comparison year-on-year.

Key Financial Highlights

Total Revenue from Operations: Stood at ₹7,119.28 crore, representing an 8.84% sequential growth compared to ₹6,541.20 crore reported in Q4 FY26. Total operations revenue was ₹6,957.47 crore in the corresponding quarter of the previous year (Q1 FY26).

Revenue from Sale of Products: Formed the core top-line driver at ₹7,077.02 crore, up from ₹6,464.26 crore in the preceding quarter. Other operating revenue contributed ₹42.26 crore.

Total Income: Recorded at ₹7,330.18 crore for Q1 FY27, including ₹210.90 crore from other income, compared to ₹6,689.36 crore in Q4 FY26.

Profit Before Tax (PBT): Came in at ₹1,081.93 crore, registering a sequential jump of 53.02% over ₹707.06 crore in the previous quarter.

Net Profit After Tax (PAT): Consolidated net profit for the period reached ₹7,85.55 crore, posting a 44.80% QoQ surge against ₹542.51 crore in Q4 FY26.

Net Profit Attributable to Owners: Stood at ₹7,89.05 crore, up from ₹554.64 crore in Q4 FY26.

Earnings Per Share (EPS): Basic EPS for the quarter was ₹9.77 (not annualised), compared to ₹6.87 in Q4 FY26 and ₹16.07 in Q1 FY26. Diluted EPS stood at ₹9.76.

Expense Breakdown and Operations

Total expenses for Q1 FY27 were reported at ₹6,248.25 crore, compared to ₹5,982.30 crore in the preceding quarter and ₹5,446.10 crore in Q1 FY26.

Cost of Materials Consumed: Stood at ₹1,356.93 crore, marginally lower than ₹1,382.15 crore in Q4 FY26.

Purchases of Stock-in-Trade: Amounted to ₹1,251.70 crore.

Employee Benefits Expense: Increased to ₹1,497.41 crore, compared to ₹1,414.25 crore in the prior quarter.

Depreciation, Impairment & Amortisation: Reduced sequentially to ₹304.24 crore from ₹382.92 crore in Q4 FY26.

Finance Costs: Remained controlled at ₹17.03 crore.

Other Expenses: Totaled ₹1,762.39 crore during the quarter.

Tax Expense & Comprehensive Income:

Total net tax expense for the quarter stood at ₹294.83 crore (comprising current tax of ₹392.78 crore and a deferred tax credit of ₹97.95 crore).

Total Comprehensive Income for Q1 FY27 reached ₹9,79.61 crore, boosted by positive other comprehensive income of ₹194.06 crore.

Capital and Reserves

As of June 30, 2026, Cipla's paid-up equity share capital stood at ₹161.57 crore (comprising equity shares with a face value of ₹2/- each). Other equity for the company as per audited figures stood at ₹34,270.39 crore.

Shares of Cipla Limited was last trading in BSE at Rs. 1393.75 as compared to the previous close of Rs. 1415.10. The total number of shares traded during the day was 188527 in over 12616 trades.

The stock hit an intraday high of Rs. 1425.85 and intraday low of 1366.20. The net turnover during the day was Rs. 262694724.00.